EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors

Emily Simonoff, Florence Mowlem, Oliver Pearson iD, Evdokia Anagnostou, Craig Donnelly, Eric Hollander, Bryan H King, James T McCracken, Lawrence Scahill, Linmarie Sikich, Andrew Pickles

Journal of Child and Adolescent Psychopharmacology · 01.05.2022 · 32 (4) · 233-241

DOI: 10.1089/cap.2021.0137 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, erschienen am 01.05.2022. Verfasst von Emily Simonoff und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child & Adolescent Psychiatry and Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Citalopram. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderCitalopramAdolescentAnxietyAnxiety DisordersChildHumansSelective Serotonin Reuptake Inhibitors

Stichwörter der Autor:innen

anxietyautismautistic disorderrandomized controlled trialselective serotonin reuptake inhibitors

Substanzen

CitalopramSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Child & Adolescent Psychiatry and Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
  • Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
  • Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.
  • Department of Pediatrics, University of Toronto, Toronto, Canada.
  • Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Autism and Obsessive Compulsive Spectrum Program, Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Oliver Pearson

Förderung

  • NIMH NIH HHS

Zitieren

APA

Simonoff, E., Mowlem, F., Pearson, O., Anagnostou, E., Donnelly, C., Hollander, E., King, B. H., McCracken, J. T., Scahill, L., Sikich, L., & Pickles, A. (2022). Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology, 32(4), 233-241. https://doi.org/10.1089/cap.2021.0137

Vancouver

Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, et al. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 2022;32(4):233-241. doi:10.1089/cap.2021.0137

BibTeX
@article{Simonoff2022,
  author = {Simonoff, Emily and Mowlem, Florence and Pearson, Oliver and Anagnostou, Evdokia and Donnelly, Craig and Hollander, Eric and King, Bryan H and McCracken, James T and Scahill, Lawrence and Sikich, Linmarie and Pickles, Andrew},
  title = {Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2022},
  volume = {32},
  number = {4},
  pages = {233--241},
  doi = {10.1089/cap.2021.0137}
}
Kostenlos starten →